Moderna Inc. buy UBS Group AG
Start price
07.05.24
/
50%
€110.94
Target price
07.05.25
€140.14
Performance (%)
-80.76%
End price
08.05.25
€21.34
Summary
This prediction ended on 08.05.25 with a price of €21.34. The BUY prediction by UBS_Group_AG for Moderna Inc. performed very badly with a performance of -80.76%. UBS_Group_AG has a follow-up prediction for Moderna Inc. where he still thinks Moderna Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Moderna Inc. | -1.572% | -1.572% | -76.002% |
| iShares Core DAX® | -1.691% | 2.604% | 29.638% |
| iShares Nasdaq 100 | 0.913% | 3.716% | 5.541% |
| iShares Nikkei 225® | -2.346% | -1.208% | -3.945% |
| iShares S&P 500 | 0.732% | 3.130% | 4.628% |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target raised by analysts at UBS Group AG from $143.00 to $151.00. They now have a "buy" rating on the stock.
Ratings data for MRNA provided by MarketBeat
In the thread Trading Moderna Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten